Randomized controlled clinical trial of the efficacy of the digital self-help program edupression.com® in mild-to-moderate unipolar depressive patients - eFICASY-Study

Medizinische Universität Wien0 个研究点目标入组 250 人开始时间: 2023年8月4日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Age 18-65 years
•ICD-107 diagnosis of a mild to moderate depressive episode (F32.0, F32.1) or recurrent depressive disorder (F33.0, F33.1) based the M.I.N.I. diagnostic interview.
•PHQ-9 depression severity score =5
•available internet access
•ability to be managed as outpatient.
•informed consent and willingness to follow the study protocol including the ability to understand the instructions provided by edupression.com®

•previous or concurrent major medical or neurological illness
•any history of non-response to either psychotherapy/eHealth interventions (min. 3 month) or medication (min. 6 weeks, adequate antidepressive drug dosing) or any kind of therapy resistance
•participants in the active phase of other interventional studies
•ICD-10 diagnosis of substance dependence within the past year, except for caffeine or nicotine
•ICD-10 diagnosis of schizophrenia, schizoaffective disorder, bipolar affective disorder, persistent mood disorders, or an anxiety disorder
•being acutely suicidal either indicated by a score =3 on item 9 (suicidal thoughts) on the PHQ-9 or according to the investigator´s opinion
•inability to comply with the study protocol or to follow the instructions of the investigating team in accordance with the Declaration of Helsinki

发起方